Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

• Asıl Yazarlar: Lucia Berti (Yazar), Martin Irmler (Yazar), Marty Zdichavsky (Yazar), Tobias Meile (Yazar), Anja Böhm (Yazar), Norbert Stefan (Yazar), Andreas Fritsche (Yazar), Johannes Beckers (Yazar), Alfred Königsrainer (Yazar), Hans-Ulrich Häring (Yazar), Martin Hrabě de Angelis (Yazar), Harald Staiger (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2015-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...